Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

LOGIFARMA - LOGÍSTICA FARMACÊUTICA S.A.

NIF 503934640
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €12,872,127 45 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €12,872,127 45 contracts
A2 · Late Publication €17,920,308,580 3,883 contracts
Contract published to BASE more than 10 days after the signing date
LOW €17,920,308,580 3,883 contracts
A5 · Threshold Splitting €70,394,719 131 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €70,394,719 131 contracts
A6 · Low Competition €11,665,936 52 contracts
Only one bidder participated in a competitive procedure
MEDIUM €11,665,936 52 contracts
A9 · Abnormal Price Reduction €20,703,094,522 2,735 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €20,703,094,522 2,735 contracts
C3 · Missing Mandatory Fields €5,374,992 163 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €5,374,992 163 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

303
€1,434,447,842
532
€1,243,722,464
105
€946,887,489
116
€919,641,495
140
€842,540,690
65
€822,325,907
41
€817,046,747
137
€777,132,881
309
€743,753,460
547
€730,060,009
58
€719,189,086
30
€701,942,653
72
€682,533,475
51
€674,054,150
151
€670,205,961
62
€668,125,628
232
€663,126,499
146
€602,216,708
169
€567,431,189
82
€520,000,474
Page 1 of 4 · 73 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 1 of 1 · 45 contracts

Medicamento Maralixibat 9.5 mg/ml Sol oral Fr 30 ml
PT · 13477658 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€739,847 2026-02-06
Aquisição Medicamento velmanase alfa inj. 10mg iv
PT · 13102540 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€388,929 2026-02-03
AQUISIÇÃO URGENTE MEDICAMENTOS
PT · 11837935 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€56,535 2025-10-03
AQUISIÇAO URGENTE MEDICAMENTOS 41013425
PT · 12112243 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€58,702 2025-07-25
Tafasitamab 200 mg Pó conc sol inj Fr IV
PT · 11727336 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€79,360 2025-07-09
1548/2025- Ajuste direto para aquisição de T1585- Trastuzumab [150 mg; pó p/ conc p/ sol p/ perf; frs] doentes em tratamento.
PT · 12201107 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€15,792 2025-06-16
Aquisição Medicamento zanubrutinib cp. 80mg
PT · 11726825 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€81,739 2025-06-11
Aquisição Medicamento tebentafusp inj.100µg/0.5ml iv
PT · 11727057 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€270,332 2025-06-06
Aquisição Medicamento cipaglucosidase alfa inj. 105mg iv _miglustato cp. 65mg
PT · 11484384 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€267,196 2025-05-22
VÁRIOS MEDICAMENTOS
PT · 11447658 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€92,803 2025-05-16
Ajuste direto para aquisição de C23175 - CEMIPLIMAB [50 MG/ML; 7 ML; SOL INJ; FRS]
PT · 11979533 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€3,561,537 2025-05-06
VÁRIOS MEDICAMENTOS
PT · 11425193 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€108,378 2025-05-06
Aquisição medicamento sapropterina cp. 100mg
PT · 11726721 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€63,120 2025-05-02
MEDICAMENTOS
PT · 11344512 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€47,601 2025-04-11
VÁRIOS MEDICAMENTOS
PT · 11342714 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€10,426 2025-04-10
VÁRIOS MEDICAMENTOS
PT · 11361526 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€66,019 2025-04-07
VÁRIOS MEDICAMENTOS
PT · 11338820 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€65,967 2025-04-02
VÁRIOS MEDICAMENTOS
PT · 11315143 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€43,093 2025-03-25
Ajuste direto para aquisição de A2015 - ATALURENO [1000 MG; GR SUSPENSÃO ORAL; SAQUETA], A2016 - ATALURENO [125 MG; GR SUSPENSÃO ORAL; SAQUETA], A2017 - ATALURENO [250 MG; GR SUSPENSÃO ORAL; SAQUETA] e M1453 - METRELEPTINA [3 MG; PÓ SOL INJ; FRS], M1454 - METRELEPTINA [5.8 MG; PÓ SOL INJ; FRS] para suprir necessidades na área da saúde
PT · 11310423 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A9 · Abnormal Price Reduction +1
€3,619,796 2025-03-25
VÁRIOS MEDICAMENTOS
PT · 11305524 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€22,274 2025-03-19
Aquisição Medicamento Maralixibat 9.5 mg/ml Sol oral Fr 30 ml
PT · 11723303 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€221,954 2025-03-10
VÁRIOS MEDICAMENTOS
PT · 11306751 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€43,704 2025-02-24
VÁRIOS MEDICAMENTOS
PT · 11263591 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€76,874 2025-02-19
VÁRIOS MEDICAMENTOS
PT · 11233577 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€16,494 2025-02-13
61/8004/2025 - Autorização de Utilização Excecional do Medicamento
PT · 11456796 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€41,860 2025-01-27
Aquisição medicamento vosoritida inj. 0.56mg sc
PT · 11464517 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€191,631 2025-01-25
VÁRIOS MEDICAMENTOS
PT · 11199195 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€27,936 2025-01-22
VÁRIOS MEDICAMENTOS
PT · 11183425 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€82,797 2025-01-13
Aquisição medicamento atalureno susp.oral saq. 250 mg
PT · 11003596 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€181,921 2024-10-18
Aquisição Medicamento sapropterina cp. 100mg
PT · 11003611 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€22,147 2024-10-08
Medicamento metreleptina inj. 5.8 mg sc_metreleptina inj. 3 mg sc
PT · 11028598 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€322,841 2024-07-18
Medicamento Metreleptina Inj 3mg S
PT · 11012594 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award +1
€149,003 2024-04-18
Medicamento Trientina cp 150 mg
PT · 11349189 · Ajuste Direto Regime G...
A1 · Repeat Direct Award C3 · Missing Mandatory Fields
€497,338 2024-04-18
Medicamento Atalureno Susp Oral 125mg_250mg
PT · 11086983 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +1
€264,613 2024-03-14
Medicamento Metreleptina inj. 3mg
PT · 10811259 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€124,169 2024-03-14
Ajuste direto para aquisição de H269 - HIDROXICARBAMIDA [100 MG; CÁP/COMP]
PT · 10731269 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication +2
€113,546 2024-02-10
61/8001/2024 - Autorização de Utilização Excecional do Medicamento
PT · 10687687 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€187,919 2024-01-18
Medicamento Atalureno Susp Oral Saq. 250mg
PT · 10806655 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€66,153 2023-11-29
AD/1542/2023 - Medicamento Migalastate 123mg
PT · 10799998 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€45,248 2023-11-22
Medicamento Sulprostona Inj 500 mcg
PT · 10374686 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€531 2023-09-06
Medicamento Atalureno saq. 250 mg
PT · 10102912 · Ajuste Direto Regime G...
A1 · Repeat Direct Award
€396,919 2023-06-30
Medicamento Atalureno 125MG
PT · 10397351 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€105,845 2023-06-01
61/8025/2023 - Autorização de Utilização Excecional do Medicamento
PT · 10207484 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€5,828 2023-05-05
DIVERSOS MEDICAMENTOS
PT · 3253625 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€12,705 2017-03-01
DIVERSOS MEDICAMENTOS
PT · 3230355 · Ajuste Direto Regime G...
A1 · Repeat Direct Award A2 · Late Publication
€12,705 2017-03-01
Overview
Total Value Won
€20,881,085,820
Contracts Won
5,652
Score 193805 · CRITICAL RISK
NIF
503934640
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • A.M. [P-5f49]
    Vogal
    since 2019-02-12
  • C.D. [P-dec9]
    Vogal
    since 2025-05-28
  • D.P. [P-47c1]
    Vogal
    since 2025-05-28
  • I.D. [P-13ce]
    Vogal
    since 2008-12-03
  • I.D. [P-13ce]
    Vogal
    since 2011-10-12
  • I.D. [P-13ce]
    vogal
    since 2017-05-31
  • J.P. [P-951b]
    Presidente
    since 2025-05-28
  • M.M. [P-e084]
    Vogal
    since 2019-02-12
  • M.M. [P-e084]
    Vogal
    since 2023-04-14
  • M.P. [P-69a5]
    Vogal
    since 2020-04-23
  • P.M. [P-3b93]
    Presidente
    since 2008-12-03
  • P.M. [P-3b93]
    Presidente
    since 2011-10-12
  • P.M. [P-3b93]
    presidente
    since 2017-05-31
  • R.M. [P-2778]
    Presidente
    since 2022-09-12
  • R.M. [P-2778]
    Presidente
    since 2023-04-14
  • R.D. [P-1f13]
    Vogal
    since 2008-12-03
  • R.D. [P-1f13]
    Vogal
    since 2011-10-12
  • A.J. [P-bc9f]
    Fiscal Único
    since 2008-12-03
  • A.J. [P-bc9f]
    Fiscal Único
    since 2011-10-12
  • D.A. [P-c2b1]
    Fiscal Único
    since 2019-02-12
  • D.A. [P-c2b1]
    Fiscal Único
    since 2023-04-14
  • J.C. [P-75e0]
    Fiscal Único
    since 2023-04-14
  • P.A. [P-2d72]
    Fiscal Único
    since 2019-02-12
  • U.A. [P-6b22]
    Fiscal Único
    since 2008-12-03
  • U.A. [P-6b22]
    Fiscal Único
    since 2011-10-12
  • A.M. [P-5f49]
    Vogal
    2023-04-14 → 2024-11-28
  • C.D. [P-54e9]
    Vogal
    2019-02-12 → 2020-04-23
  • F.M. [P-351d]
    Vogal
    2024-11-28 → 2025-05-27
  • I.D. [P-13ce]
    Vogal
    2019-02-12 → 2019-02-12
  • I.D. [P-13ce]
    Vogal
    2023-04-14 → 2024-12-09
  • J.P. [P-9310]
    Vogal
    2025-11-17 → 2026-01-14
  • M.M. [P-e084]
    Vogal
    2025-05-28 → 2025-05-28
  • M.M. [P-e084]
    Vogal
    until 2025-11-13
  • M.A. [P-6e88]
    Vogal
    2023-04-14 → 2025-05-28
  • P.J. [P-7343]
    Presidente
    2019-02-12 → 2021-09-10
  • P.M. [P-976f]
    Vogal
    2023-04-14 → 2025-01-08
  • P.M. [P-3b93]
    Vogal
    2019-02-12 → 2019-02-12
  • P.M. [P-3b93]
    Vogal
    2023-04-14 → 2024-12-09
  • R.M. [P-2778]
    Vogal
    2025-05-28 → 2025-05-28
  • R.M. [P-2778]
    Vogal
    until 2026-01-14
  • R.D. [P-1f13]
    vogal
    2017-05-31 → 2019-02-12
  • T.G. [P-26e1]
    Vogal
    2019-02-12 → 2022-02-04
  • A.J. [P-bc9f]
    Fiscal Único
    2017-05-31 → 2019-02-12
  • U.A. [P-6b22]
    Fiscal Único
    2017-05-31 → 2019-02-12
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned